Redefine Surgery closes an oversubscribed pre-seed round, raising $10 million to support the development of its surgical intelligence platform.
PRIVATESep 24, 2026
Amount Raised
$10 Million
Round Type
Pre-Seed
New JerseyBiotechnologyHealth CareArtificial IntelligenceMedicalMedical Device
Investors
Surgeon Investors
Description
Redefine Surgery, a medical technology company, has closed an oversubscribed pre-seed financing round. This round brings the total capital raised to $10 million, backed mainly by surgeon investors. The funding will support the continued development of its surgical intelligence platform. This announcement follows a recent partnership with Catalyst OrthoScience.
Company Information
Company
Redefine Surgery
Location
New Jersey, United States
About
Redefine Surgery is a medical technology company focused on developing physical AI solutions for surgical applications. They aim to enhance surgical intelligence and improve outcomes through innovative technology. The company is preparing for the commercialization of its platform, supported by significant investment from surgeon investors.
Fundz sees it the moment Redefine Surgery raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
New JerseyBiotechnologyHealth CareArtificial IntelligenceMedicalMedical Device